Dentists in Templeton, CA Accepting Medicare
4 Dentists found. Showing 1 - 4
 Dr. Rick William Wearda Dentist Medicare: Not Enrolled in Medicare Practice Location: 1050 Las Tablas Rd Ste 8, Templeton, CA 93465 Phone: 805-434-2811 Fax: 805-434-2243 |
Dr. Justin R Evans, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 294 S Main St, Suite #a, Templeton, CA 93465 Phone: 805-434-1420 |
Dr. Walter S Kohnke, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 325 Posada Ln Ste C, Templeton, CA 93465 Phone: 805-542-6702 Fax: 805-542-6796 |
Dr. Loren Bruce Kirk, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 125 Conover Ln, Templeton, CA 93465 Phone: 805-434-1567 |
News Archive
Mysterious particle found in the blood of people with sepsis
Researchers at La Jolla Institute for Immunology have found that people with sepsis have never-before-seen particles in their blood.
Research offers further evidence that diet affects gastrointestinal illnesses
Research being presented at Digestive Disease Week- offers further evidence that diet affects gastrointestinal illnesses, such as gallstones and celiac disease, and that some patients who think their digestive problems are caused by lactose intolerance are actually reacting to a psychological disorder.
Affinity Health Plan's Medicare Advantage plans to be expanded into five counties
On October 1, 2013, Affinity Health Plan's Medicare Advantage plans, currently offered in the five boroughs of New York City, will become available in Nassau, Suffolk, Westchester, Rockland and Orange counties.
Cerulean commences dosing in CRLX101-Avastin combination study for metastatic renal cell carcinoma
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.
Researchers develop artificial enzymatic pathway for synthesizing isoprenoids in E. coli
Researchers from North Carolina State University have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli.
› Verified 5 days ago
Counselors
Clinical Social Workers
Occupational Therapists
Dentists